Aim: To describe the characteristics and medication treatment patterns, healthcare resource
utilization (HRU), and associated costs in Japanese patients with systemic lupus …

Aim To describe the healthcare resource utilization (HRU), direct medical costs and clinical
characteristics for Japanese patients with mild, moderate or severe systemic lupus …

We aimed to estimate the annual direct medical costs of South Korean systemic lupus
erythematosus (SLE) patients, and their predictors. The 2010 annual direct medical costs of …

Background: To estimate the annual direct costs and cost-drivers associated with systemic
lupus erythematosus (SLE) patients in China. Methods: A multi-center, cross-sectional study …

Objective. To quantify healthcare utilization and costs by disease severity for patients with
systemic lupus erythematosus (SLE) in the United States. Methods. We conducted …

Objective: To assess healthcare resource utilization and costs in a cohort of US managed
care patients with systemic lupus erythematosus (SLE). Methods: Claims data from a large …

Objective To evaluate the annual direct medical cost of systemic lupus erythematosus (SLE)
in Canada by disease severity and to estimate the incremental cost associated with disease …

Objective A structured review of the literature was undertaken to examine the direct costs of
adult systemic lupus erythematosus (SLE) in a US population. Methods English‐language …

Systemic lupus Erythematosus (SLE) is a chronic multi-system autoimmune disease that can
affect a person's physical, mental, and social life. It imposes a substantial economic burden …

Objective. Healthcare utilization and costs associated with systemic lupus erythematosus
(SLE) in a US Medicaid population were examined. Methods. Patients≥ 18 years old with …